| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UKNOWN |
| UNII: | AB6MNQ6J6L |
Structure
| InChI Key | KDYFGRWQOYBRFD-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C4H6O4 |
| Molecular Weight | 118.09 |
| AlogP | -0.06 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 74.6 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 8.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 3000-85300 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 15741 |
| ChEMBL | CHEMBL576 |
| DrugBank | DB00139 |
| DrugCentral | 2487 |
| EPA CompTox | DTXSID6023602 |
| FDA SRS | AB6MNQ6J6L |
| Human Metabolome Database | HMDB0000254 |
| Guide to Pharmacology | 3637 |
| KEGG | C00042 |
| PDB | SIN |
| SureChEMBL | SCHEMBL829 |
| ZINC | ZINC000000895030 |
CONTENTS